Invex Therapeutics Ltd
-
Ticker
IXC
-
Industry
Biotechnology More
-
Sector
Healthcare More
- 1-10 Employees
- Based in Subiaco, Australia
Invex Therapeutics is a biopharmaceutical company focused on the repurposing of an already approved drug, Exenatide, for efficacious treatment of neurological conditions derived from or involving raised intracranial pressure, such as Idiopathic Intracranial Hypertension (IIH), acute stroke and traumatic brain injury. Invex has trademarked its repurposed Exenatide as Presendin™.
Invex Therapeutics Ltd
Most Recent Annual Report
MOST RECENT
2021 Annual Report
Older/Archived Annual Reports